How many employees does Sarepta Therapeutics, Inc. have?

Sarepta Therapeutics, Inc. reported 835 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 2, 2026. That is down 39.1% from a year earlier.

What is Sarepta Therapeutics, Inc.'s revenue per employee?

Sarepta Therapeutics, Inc. brought in $2.20B of revenue in fiscal Dec 2025, which is $2.63M per employee. That ranks 5 of 108 companies we track in Biotechnology, where the median is $459K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Sarepta Therapeutics, Inc. employees and revenue per employee

SRPT · Biotechnology · $1.88B market cap

Sarepta Therapeutics, Inc. had 835 employees at the end of fiscal Dec 2025, down 39.1% from a year earlier. Revenue for the year was $2.20B, up 15.6% from a year earlier, or $2.63M per employee. Revenue held up or grew while headcount stayed flat or fell.

Employees

835

-39.1% YoY

Revenue

$2.20B

+15.6% YoY

Revenue / employee

$2.63M

Peer median $459K

Rank in industry

5 of 108

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2016

Hover a year for the numbers.

SRPT employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	835	$2.20B	$2.63M	-39.1%	+15.6%
Dec 2024	1,372	$1.90B	$1.39M	+4.4%	+53.0%
Dec 2023	1,314	$1.24B	$946K	+13.1%	+33.3%
Dec 2022	1,162	$933M	$803K	+38.3%	+32.9%
Dec 2021	840	$702M	$836K	-3.0%	+30.0%
Dec 2020	866	$540M	$624K	+16.6%	+41.8%
Dec 2019	743	$381M	$513K	+48.9%	+26.5%
Dec 2018	499	$301M	$603K	+95.7%	+94.7%
Dec 2017	255	$155M	$606K	+29.4%	+2751.6%
Dec 2016	197	$5.4M	$28K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Sarepta Therapeutics, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
HALO Halozyme Therapeutics, Inc.	423	$1.40B	$3.30M	Efficient growth
SRPT Sarepta Therapeutics, Inc.	835	$2.20B	$2.63M	Leaner
UTHR United Therapeutics Corporation	1,400	$3.18B	$2.27M	Efficient growth
EXEL Exelixis, Inc.	1,077	$2.32B	$2.15M	Leaner
PTCT PTC Therapeutics, Inc.	991	$1.73B	$1.75M	Efficient growth
NBIX Neurocrine Biosciences, Inc.	2,000	$2.86B	$1.43M	Efficient growth
BMRN BioMarin Pharmaceutical Inc.	3,221	$3.22B	$1.00M	Efficient growth
MRNA Moderna, Inc.	4,700	$1.94B	$414K	Contracting
FTRE Fortrea Holdings Inc.	14,300	$2.72B	$190K	Leaner

Every Healthcare company

Questions about Sarepta Therapeutics, Inc.

How many employees does Sarepta Therapeutics, Inc. have?: Sarepta Therapeutics, Inc. reported 835 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 2, 2026. That is down 39.1% from a year earlier.
What is Sarepta Therapeutics, Inc.'s revenue per employee?: Sarepta Therapeutics, Inc. brought in $2.20B of revenue in fiscal Dec 2025, which is $2.63M per employee. That ranks 5 of 108 companies we track in Biotechnology, where the median is $459K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare SRPT with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Sarepta Therapeutics, Inc.'s annual reports (Form 10-K), latest filed March 2, 2026. This is data, not a recommendation to buy or sell SRPT.